Baihua Pharmaceuticals: The controlling shareholder is planning a share transfer, and the stock remains suspended.

2026-04-03 01:29:31

People’s Finance News, April 1. In an April 1 announcement, Huayuan Pharmaceutical (600721) said that its controlling shareholder and actual controller, Mi Zaiqi, Mi Enhua, and Yang Xiaoling, are currently planning matters related to the agreement-based transfer of the company’s shares. This matter may lead to a change in the company’s control. As of the date of disclosure of the announcement, the above matters are still in the planning stage. The company’s stock will continue to be suspended from market opening on April 2, 2026 (Thursday), and the expected continued suspension period will not exceed 3 trading days.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.